Who Paid My Doc
GelPOINT Path Transanal Access Platform
Device Specialty Access
PDI 00607915137922
General payments
$168,113
Research payments
$25,125
Through program year 2025, $168,113 in general payments and $25,125 in research payments were reported against GelPOINT Path Transanal Access Platform (Specialty Access).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $16,530 | 3 |
| 2025 | Research | $25,125 | 1 |
| 2024 | General | $8,173 | 3 |
| 2023 | General | $88,811 | 9 |
| 2022 | General | $31,794 | 4 |
| 2021 | General | $22,805 | 15 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
34 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.